Today: 9 June 2026
Dow Drops 537 Points With After-Hours Selling Threatening Wall Street AI Rally

Dow Drops 537 Points With After-Hours Selling Threatening Wall Street AI Rally

NEW YORK, May 15, 2026, 20:08 EDT

  • U.S. stock ETFs traded lower late after the S&P 500, Dow, and Nasdaq all lost more than 1%.
  • Oil prices and Treasury yields both surged, shaking up Fed-rate bets and putting pressure on high AI-stock valuations.
  • Berkshire’s filings on Delta and Macy’s grabbed attention after the bell. Chip stocks remained under pressure.

U.S. stock ETFs slipped further in Friday’s after-hours session, deepening the day’s Wall Street decline. Higher oil prices, a jump in Treasury yields, and fresh Fed rate worries pressured the market’s top tech names.

SPDR S&P 500 ETF dropped 0.25% after hours, Investing.com’s data showed. The Invesco QQQ Trust, which tracks the Nasdaq 100, lost 0.34%. Dow ETF eased 0.18% and iShares Russell 2000 ETF dipped 0.28%. Nvidia, Microsoft, Apple, Micron and Tesla all traded lower after the close in light volume.

Stocks had surged to new highs this week as AI bets grew, but Friday’s reversal hit hard. The S&P 500 and Nasdaq had closed at records before losing ground, with those gains undone as higher borrowing costs started to weigh on expensive names.

Dow Jones closed down 537.29 points, or 1.07%, at 49,526.17. The S&P 500 slid 92.74 points, or 1.24%, to end at 7,408.50. The Nasdaq lost 410.08 points, or 1.54%, to 26,225.15. The S&P 500 still managed its seventh weekly gain, but the Nasdaq broke a six-week run.

Selling picked up but didn’t turn into a panic. Bond yields ticked higher as oil’s bounce added to worries about inflation. Reuters said the 10-year Treasury yield hit 4.597%. The 30-year yield was at 5.122%. U.S. crude settled 4.2% higher at $105.42 a barrel. Brent ended up 3.35% at $109.26.

Kenny Polcari at Slatestone Wealth told Reuters the market had “gotten way ahead of itself” and was caught up in a “momentum AI trade.” Chip stocks dropped sharply. The Philadelphia SE Semiconductor Index lost 4%. Nvidia fell 4.4%, AMD dropped 5.7%, and Intel slid 6.2%. Reuters

Microsoft moved up during regular trading. Bill Ackman’s Pershing Square took a new stake in the company and sold its Alphabet position to make room. Ackman called Microsoft’s valuation “highly compelling.” Matt Britzman at Hargreaves Lansdown said the move lined up with his belief that Microsoft could see a re-rating. Reuters

Berkshire Hathaway was back in the after-hours headlines with a filing showing a new $2.65 billion Delta Air Lines position, a small Macy’s stake, and it cut smaller holdings like Amazon, UnitedHealth, Visa and Mastercard. Delta shares were up 3.3% and Macy’s added 6.3% post-market, Reuters said.

Fed rate outlook weighed too. Investors put about 60% odds on the Fed’s benchmark rate rising by 25 basis points by the January meeting, according to CME FedWatch and Reuters. A basis point is one-hundredth of a percentage point.

Prediction markets sent a comparable but not exact read. On Polymarket, odds for zero Fed rate cuts in 2026 priced at 67%. Traders gave a 32% chance to a Fed rate hike sometime this year. Over at Kalshi’s Federal Reserve page, odds for a hike before 2027 stood at 25% and 39% before July 2027. These numbers are bets from traders, not forecasts by banks.

Geopolitics are in play too. According to Polymarket’s economy page, just a 6% chance is priced in for Strait of Hormuz traffic to be back to normal by the end of May, and 30% for the end of June. Traders are not betting on a fast resolution to the oil-supply shock.

Bears face the chance that after-hours swings might not stick by Monday, particularly if oil prices drop or shipping fears ease over the weekend. Bulls, though, have a straightforward risk. If crude and yields remain elevated, investors could keep backing away from pricey AI stocks and small caps. The Russell 2000 dropped 2.4% on Friday.

The market isn’t chasing records at this point. Instead, traders are watching rates. It’s a softer tape, with Monday’s open looking less about earnings and more about moves in oil, bonds, and whatever signal comes next from the Fed.

Stock Market Today

  • Rocket Lab Stock Price Forecast: AI Analyst Cautions Despite 60% Surge
    June 9, 2026, 10:12 AM EDT. Shares of Rocket Lab USA ($RKLB) have jumped more than 60% year-to-date due to increased demand for small-satellite launches. Despite the rally, AI-driven analysis from TipRanks highlights caution, urging investors to consider potential market volatility and competitive pressures. Rocket Lab's growth taps into expanding satellite deployment, but risks remain in a crowded aerospace sector. Investors should balance optimism with these cautionary signals from advanced analytics.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
SpaceX Nasdaq Listing Draws Closer as IPO Timeline Accelerates
Previous Story

SpaceX Nasdaq Listing Draws Closer as IPO Timeline Accelerates

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Next Story

US Stock Market Today: Live Updates 16.05.2026

Go toTop